Supporting post-workout recovery
2008 Aug;31(8):1079-85
Since then, a number of triple agonists have entered clinical development, with one in phase three clinical studies but have yet to reach the market (Capozzi, DiMarchi, Tschp)
E.Sobrino-PlataJ.Montero-PalmeroM
GSH1 Gamma glutamylcysteine synthetase, GSH2 Glutathione synthetase, GLR1 Glutathione oxidoreductase, GRX1-8 Glutaredoxins, GTO1-3 Glutathione transferases Omega-like, ROS Reactive oxygen species, RX Xenobiotics, GTT1-2 Glutathione transferases, GRX1-2 Glutaredoxins, YCF1 Vacuolar glutathione S-conjugate transporter, ECM38 Gamma-glutamyltranspeptidase, DUG1-3 GSH degradosomal complex -Glutamylcysteine synthetase (GSS1